[{"data": {"name": "Higher Risk of Infections with PI3K-AKT-mTOR Pathway Inhibitors in Patients with Advanced Solid Tumors on Phase I Clinical Trials", "@type": "ScholarlyArticle", "genre": "journal-article", "author": [{"name": "S. Rafii", "@type": "Person"}, {"name": "D. Roda", "@type": "Person"}, {"name": "E. Geuna", "@type": "Person"}, {"name": "B. Jimenez", "@type": "Person"}, {"name": "K. Rihawi", "@type": "Person"}, {"name": "M. Capelan", "@type": "Person"}, {"name": "T. A. Yap", "@type": "Person"}, {"name": "L. R. Molife", "@type": "Person"}, {"name": "S. B. Kaye", "@type": "Person"}, {"name": "J. S. de Bono", "@type": "Person"}, {"name": "U. Banerji", "@type": "Person"}], "@context": "http://schema.org/", "encoding": [{"@type": "MediaObject", "contentUrl": "http://clincancerres.aacrjournals.org/content/21/8/1869.full.pdf", "encodingFormat": "application/pdf"}], "publisher": {"name": "American Association for Cancer Research (AACR)", "@type": "Organization"}, "identifier": [{"@type": "PropertyValue", "value": "10.1158/1078-0432.ccr-14-2424", "propertyID": "DOI"}, {"@type": "PropertyValue", "value": "CCd8CrJRXtevq-CTgcJR8c4uD1b-CDi34Tmb1q3Qq-CRhieZYBpBDun", "propertyID": "ISCC"}], "datePublished": "2015-02-03"}, "schema": "schema.org", "mediatype": "application/ld+json"}]